Emfib 250 mg Gefitinib Tablets

WHAT
IS EMFIB TABLETS?

Emfib Gefitinib is a
type of drug called a tyrosine kinase inhibitor (TKI), also known as a cancer
growth inhibitor. Kinases are proteins in the body that regulate how the cells
grow and divide. Gefitinib blocks (inhibits) the protein from sending signals to
the cancer cells that make them grow and divide.

USES OF EMFIB TABLETS:

Emfib 250mg Tablet is used
to treat some people with non-small cell lung cancer (NSCLC). It only works for
cancers that have an abnormal form of a protein called epidermal growth factor
receptor (EGFR). Tests are done on the cancer cells from a lung biopsy or
previous surgery to check the level of EGFR. 

Emfib 250 mg Tablet is an
anticancer medicine which is used in the treatment of cancer of the lungs. It
should only be used under the supervision of a qualified physician.

POSSIBLE
SIDE EFFECTS:

All medicines may cause side
effects, but many people have no, or minor, side effects. Check with your
doctor if any of these most COMMON side effects persist or become bothersome:

Acne; diarrhea; dry skin; loss of appetite; mouth ulcers; nausea; unusual
weakness; vision problems; vomiting; weight loss.

COMMON SIDE EFFECTS MAY
INCLUDE:

The
following is a list of possible side effects that may occur from the use of
Gefitrust Tablet. This is not a comprehensive list. These side-effects are
possible but do not always occur. Some of the side-effects may be rare but
serious. Consult your physician if you observe any of the following
side-effects, especially if they do not go away.

Severe allergic reactions
(rash; hives; itching; difficulty breathing; tightness in the chest; swelling
of the eyelids, mouth, face, lips, or tongue); cough; dark urine; dizziness;
eye irritation or pain; extreme fatigue; fever; persistent diarrhea; stomach
pain; swelling of the ankles or feet; yellowing of the skin or eyes.

DRUGS PRECAUTIONS:

Take this medicine in the dose and duration as advised by your doctor.
Swallow it as a whole. Do not chew, crush or break it. Emfib 250mg Tablet may
be taken with or without food, but it is better to take it at a fixed time.

Emfib 250 mg Tablet is an
anti-cancer medication. It works by blocking the action of the abnormal protein
that signals cancer cells to multiply. This helps to stop or slow the spread of
cancer cells.

DRUGS INTERACTIONS:

The concomitant administration of Emfib
with simvastatin is contraindicated. The risk of myopathy and rhabdomyolysis is
increased with combined Emfib and HMG-COA reductase inhibitor therapy. Myopathy
or rhabdomyolysis with or without acute renal failure have been reported as
early as three weeks after initiation of combined therapy or after several
months. There is no assurance that periodic monitoring of creatine kinase will
prevent the occurrence of severe myopathy and kidney damage.

Emfib AUC was reduced by 30% when Emfib
600 mg was given simultaneously with resin-granule drugs such as colestipol (5
g). Administration of the drugs two hours or more apart is recommended because
Emfib exposure was not significantly affected when it was administered 2 hours
apart from colestipol.